Original Research

A double-blind, randomized trial, including frequent patient–physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study

Hassanein M, Abdallah K, Schweizer A

Vascular Health and Risk Management 2014, 10:319-326

Published Date: 28 May 2014